Loading...
XNAS
ATRI
Market cap809mUSD
Aug 20, Last price  
459.92USD
Name

Atrion Corp

Chart & Performance

D1W1MN
P/E
41.70
P/S
4.78
EPS
11.03
Div Yield, %
Shrs. gr., 5y
-1.07%
Rev. gr., 5y
2.12%
Revenues
169m
-7.73%
66,081,00072,089,00081,020,00088,540,00095,895,000100,643,000108,569,000117,704,000119,062,000131,993,000140,762,000145,733,000143,487,000146,595,000152,448,000155,066,000147,591,000165,009,000183,506,000169,326,000
Net income
19m
-44.55%
6,470,0008,958,00010,765,00014,006,00015,667,00016,843,00020,952,00026,038,00023,629,00026,582,00027,808,00028,925,00027,581,00036,593,00034,255,00036,761,00032,115,00033,055,00035,008,00019,411,000
CFO
20m
-30.51%
11,189,00010,059,00012,813,00022,705,00019,487,00028,399,00031,241,00030,716,00029,369,00036,576,00031,223,00040,427,00037,403,00047,037,00043,236,00042,465,00039,220,00038,798,00028,789,00020,006,000
Dividend
Jun 14, 20242.2 USD/sh
Earnings
Aug 06, 2025

Profile

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
IPO date
Mar 18, 1980
Employees
722
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
169,326
-7.73%
183,506
11.21%
Cost of revenue
146,747
143,819
Unusual Expense (Income)
NOPBT
22,579
39,687
NOPBT Margin
13.33%
21.63%
Operating Taxes
2,964
5,609
Tax Rate
13.13%
14.13%
NOPAT
19,615
34,078
Net income
19,411
-44.55%
35,008
5.91%
Dividends
(15,311)
(14,620)
Dividend yield
2.30%
1.46%
Proceeds from repurchase of equity
(1,724)
(26,419)
BB yield
0.26%
2.64%
Debt
Debt current
Long-term debt
240
Deferred revenue
(240)
Other long-term liabilities
2,944
3,185
Net debt
(14,181)
(34,552)
Cash flow
Cash from operating activities
20,006
28,789
CAPEX
(22,319)
(33,736)
Cash from investing activities
(4,137)
(15,283)
Cash from financing activities
(17,035)
(41,039)
FCF
(2,556)
(5,218)
Balance
Cash
6,256
25,883
Long term investments
8,165
8,669
Excess cash
5,955
25,377
Stockholders' equity
382,096
378,024
Invested Capital
239,878
217,275
ROIC
8.58%
17.42%
ROCE
9.10%
16.10%
EV
Common stock shares outstanding
1,761
1,790
Price
378.79
-32.29%
559.45
-20.63%
Market cap
667,049
-33.39%
1,001,416
-21.86%
EV
652,868
966,864
EBITDA
37,677
53,499
EV/EBITDA
17.33
18.07
Interest
149
988
Interest/NOPBT
0.66%
2.49%